Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Joseph Mrus"'
Autor:
Miranda Murray, Federico Pulido, Anthony Mills, Moti Ramgopal, Roger LeBlanc, Hans Jaeger, Viviam Canon, David Dorey, Sandy Griffith, Joseph Mrus, William Spreen, David Margolis
Publikováno v:
HIV Research & Clinical Practice, Vol 20, Iss 4-5, Pp 111-122 (2019)
Background: Long-acting (LA) injectable antiretroviral therapy (ART) is a novel modality currently under development as an alternative to daily oral ART. Objective: The LATTE-2 study (ClinicalTrials.gov identifier NCT02120352) showed that cabotegravi
Externí odkaz:
https://doaj.org/article/f6a3b93b9b2d4775a89b193f0be7bb9a
Autor:
Douglas Ward, Moti Ramgopal, David J. Riedel, Cindy Garris, Shelly Dhir, John Waller, Jenna Roberts, Katie Mycock, Alan Oglesby, Bonnie Collins, Megan Dominguez, James Pike, Joseph Mrus
Publikováno v:
AIDS Research and Treatment, Vol 2020 (2020)
Background. Dolutegravir-based 2-drug regimens (DTG 2DRs) are now accepted as alternatives to 3-drug regimens for HIV antiretroviral treatment (ART); however, literature on physician drivers for prescribing DTG 2DR is sparse. This study evaluated tre
Externí odkaz:
https://doaj.org/article/174002e8d8b44a1282599b7347aaca5c
Publikováno v:
AIDS Research and Treatment, Vol 2013 (2013)
This observational analysis examined the clinical outcomes of patients receiving etravirine-(ETR-) based therapy, particularly with protease inhibitors (PIs) other than darunavir (DRV) and with raltegravir (RAL). Data included treatment-experienced a
Externí odkaz:
https://doaj.org/article/b8dba1bc6d4449e59571487984362741
Autor:
Thomas Kakuda, Vanitha Sekar, Peter Vis, Bruce Coate, Robert Ryan, David Anderson, Guy De La Rosa, Joseph Mrus
Publikováno v:
AIDS Research and Treatment, Vol 2012 (2012)
Objectives. Evaluation of pharmacokinetics and pharmacodynamics of darunavir and etravirine among HIV-1–infected, treatment-experienced adults from GRACE, by sex and race. Methods. Patients received darunavir/ritonavir 600/100mg twice daily plus ot
Externí odkaz:
https://doaj.org/article/69d57b1edb1e4c86a84e063601f34ea0
Autor:
Judith Feinberg, Michael Saag, Kathleen Squires, Judith Currier, Robert Ryan, Bruce Coate, Joseph Mrus
Publikováno v:
AIDS Research and Treatment, Vol 2011 (2011)
Background. We report health-related QoL (HRQoL) from GRACE (Gender, Race, And Clinical Experience) study by sex and race over 48 weeks. Methods. 429 treatment-experienced adults (HIV-1 RNA≥1000 copies/mL) received darunavir/ritonavir 600/100 mg tw
Externí odkaz:
https://doaj.org/article/7ab2fe6bab284dc5900dcae6b572a307
Publikováno v:
Journal of helminthology. 92(3)
Soil-transmitted helminthiasis (STH) is caused by Ascaris lumbricoides (roundworm), Trichuris trichiura (whipworm), and Ancylostoma duodenale and Necator americanus (hookworms). Mebendazole is one of the recommended preventive chemotherapy agents for
Autor:
Andrew Friedman, Alan Baseman, Netsanet Workneh, Zeleke Mekonnen, Joseph Mrus, Benny Baeten, Hailemaryam Alemu, Steven Silber, Bruno Levecke, Peter Hu, Marc Engelen, Irenee Umulisa, Ermias Diro, Peter Steinmann
Publikováno v:
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
The American Journal of Tropical Medicine and Hygiene
The American Journal of Tropical Medicine and Hygiene
This randomized, double-blind, placebo-controlled study evaluated the efficacy and safety of a new chewable, rapidly-disintegrating mebendazole (MBZ) 500 mg tablet for Ascaris lumbricoides and Trichuris trichiura infection treatment. Pediatric patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90697f503909559f5f063ec2f668f421
https://hdl.handle.net/1854/LU-8559660
https://hdl.handle.net/1854/LU-8559660
Autor:
Joseph Mrus, Alessandra Baldini, Ralph DeMasi, James Witek, Donghan Luo, Bruce Coate, Stefan Zeuzem
Publikováno v:
Journal of Hepatology. 60:1112-1117
Anemia is a common adverse event associated with telaprevir-based triple therapy of chronic, genotype 1 hepatitis C. Identification of patients at risk of developing anemia could allow evaluation of suitability for therapy, and aid in determining fre
Autor:
Alan Oglesby, Collins Bonnie, David J. Riedel, Joseph Mrus, Douglas J. Ward, Moti Ramgopal, James Pike, Steven F Scheibel, J. Roberts, Dominguez Megan, Cindy Garris, Shelly Dhir, Katie Mycock, John Waller
Publikováno v:
Open Forum Infectious Diseases
Background Three-drug regimens (3DRs) have long been the mainstay of antiretroviral treatment (ART) for HIV. Dolutegravir-based two-drug regimens (DTG 2DRs) are now accepted alternatives to 3DRs, with the first 2DR single tablet regimen (STR), Juluca
Autor:
Thomas N. Kakuda, Carmen D. Zorrilla, Joseph Mrus, Bryan Baugh, Kimberley Brown, R Falcon, Salih Yasin, Bruce Coate, Olayemi Osiyemi, R Wright, P Verboven
Publikováno v:
HIV Medicine
Objectives Antiretroviral therapy during pregnancy is recommended to reduce the risk of mother-to-child transmission of HIV and for maternal care management. Physiological changes during pregnancy can affect pharmacokinetics, potentially altering pha